Paralel Advisors LLC Buys 6,920 Shares of Genpact Limited (NYSE:G)

Paralel Advisors LLC lifted its holdings in shares of Genpact Limited (NYSE:G - Free Report) by 10.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 76,196 shares of the business services provider's stock after buying an additional 6,920 shares during the period. Paralel Advisors LLC's holdings in Genpact were worth $3,273,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. SRH Advisors LLC purchased a new position in Genpact in the 4th quarter worth about $26,000. Atlas Capital Advisors Inc. grew its position in Genpact by 55.8% in the fourth quarter. Atlas Capital Advisors Inc. now owns 603 shares of the business services provider's stock worth $26,000 after acquiring an additional 216 shares in the last quarter. Manchester Capital Management LLC bought a new stake in Genpact in the fourth quarter worth $38,000. Smartleaf Asset Management LLC raised its stake in shares of Genpact by 416.5% in the 4th quarter. Smartleaf Asset Management LLC now owns 971 shares of the business services provider's stock valued at $41,000 after acquiring an additional 783 shares in the last quarter. Finally, UMB Bank n.a. raised its position in shares of Genpact by 55.7% in the fourth quarter. UMB Bank n.a. now owns 1,210 shares of the business services provider's stock valued at $52,000 after purchasing an additional 433 shares during the period. Institutional investors own 96.03% of the company's stock.

Genpact Stock Up 0.0 %

G stock traded up $0.01 during mid-day trading on Tuesday, reaching $48.02. 382,800 shares of the company traded hands, compared to its average volume of 1,348,976. The company has a quick ratio of 1.85, a current ratio of 2.16 and a debt-to-equity ratio of 0.50. The stock has a market cap of $8.44 billion, a price-to-earnings ratio of 16.91, a P/E/G ratio of 1.84 and a beta of 1.06. The firm's 50 day moving average price is $50.97 and its 200 day moving average price is $45.89. Genpact Limited has a fifty-two week low of $30.23 and a fifty-two week high of $56.76.

Genpact (NYSE:G - Get Free Report) last announced its quarterly earnings data on Thursday, February 6th. The business services provider reported $0.82 EPS for the quarter, missing the consensus estimate of $0.86 by ($0.04). Genpact had a return on equity of 22.50% and a net margin of 10.77%. As a group, equities research analysts predict that Genpact Limited will post 3.21 EPS for the current fiscal year.

Genpact Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Wednesday, March 26th. Shareholders of record on Tuesday, March 11th were paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a yield of 1.42%. The ex-dividend date of this dividend was Tuesday, March 11th. This is a boost from Genpact's previous quarterly dividend of $0.15. Genpact's payout ratio is currently 23.94%.

Insider Buying and Selling at Genpact

In other Genpact news, CEO Balkrishan Kalra sold 13,600 shares of the company's stock in a transaction that occurred on Thursday, March 13th. The stock was sold at an average price of $48.89, for a total transaction of $664,904.00. Following the completion of the transaction, the chief executive officer now owns 310,246 shares of the company's stock, valued at $15,167,926.94. This represents a 4.20 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Company insiders own 2.80% of the company's stock.

Analyst Ratings Changes

Several research firms have commented on G. Mizuho upped their price target on Genpact from $45.00 to $55.00 and gave the company a "neutral" rating in a report on Monday, February 10th. Jefferies Financial Group upgraded Genpact from a "hold" rating to a "buy" rating and increased their price objective for the company from $44.00 to $55.00 in a research report on Tuesday, January 21st. Needham & Company LLC raised their target price on shares of Genpact from $55.00 to $65.00 and gave the company a "buy" rating in a research note on Friday, February 7th. Finally, TD Cowen raised Genpact from a "hold" rating to a "buy" rating and increased their target price for the company from $45.00 to $60.00 in a research note on Friday, February 7th. Six research analysts have rated the stock with a hold rating and three have issued a buy rating to the stock. According to MarketBeat.com, the company currently has a consensus rating of "Hold" and a consensus price target of $48.44.

Genpact Profile

Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.